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Background: Curcuma purpurascens BI. (Zingiberaceae) commonly known as ‘Koneng Tinggang’ and ‘Temu Tis’ is a
Javanese medicinal plant which has been used for numerous ailments and diseases in rural Javanese communities.
In the present study, the apoptogenic activity of dichloromethane extract of Curcuma purpurascens BI. rhizome
(DECPR) was investigated against HT-29 human colon cancer cells.
Methods: Acute toxicity study of DECPR was performed in Sprague–Dawley rats. Compounds of DECPR were
analyzed by the gas chromatography–mass spectrometry–time of flight (GC-MS-TOF) analysis. Cytotoxic effect of
DECPR on HT-29 cells was analyzed by MTT and lactate dehydrogenase (LDH) assays. Effects of DECPR on reactive
oxygen species (ROS) formation and mitochondrial-initiated events were investigated using a high content screening
system. The activities of the caspases were also measured using a fluorometric assay. The quantitative PCR analysis was
carried out to examine the gene expression of Bax, Bcl-2 and Bcl-xl proteins.
Results: The in vivo acute toxicity study of DECPR on rats showed the safety of this extract at the highest dose of
5 g/kg. The GC-MS-TOF analysis of DECPR detected turmerone as the major compound in dichloromethane extract.
IC50 value of DECPR towards HT-29 cells after 24 h treatment was found to be 7.79 ± 0.54 μg/mL. In addition, DECPR
induced LDH release and ROS generation in HT-29 cells through a mechanism involving nuclear fragmentation and
cytoskeletal rearrangement. The mitochondrial-initiated events, including collapse in mitochondrial membrane
potential and cytochrome c leakage was also triggered by DECPR treatment. Initiator caspase-9 and executioner
caspase-3 was dose-dependently activated by DECPR. The quantitative PCR analysis on the mRNA expression of
Bcl-2 family of proteins showed a significant up-regulation of Bax associated with down-regulation in Bcl-2 and
Bcl-xl mRNA expression.
Conclusions: The findings presented in the current study showed that DECP suppressed the proliferation of HT-29
colon cancer cells and triggered the induction of apoptosis through mitochondrial-dependent pathway.
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In 1972, Kerr, Wyllie and Currie officially coined the term
“apoptosis” [1-3] and the nematode of Caenorhabditis ele-
gans was researched for the understanding of the mecha-
nisms of apoptosis process involved in the mammalian
cells [4,5]. Roughly 10 billion cells die through apoptosis
daily in the adult human body indicating the importance of
this process for maintaining homeostasis of the body [6].
Any perturbation in the regulation of apoptosis, cell sur-
vival and cell proliferation can lead to the progression of
cancer cells [7]. Therefore, investigation for novel chemo-
therapeutic agents capable of inducing apoptosis specific-
ally in cancer cells has been extensively carried out in order
to effect cancer treatment along with a reduction in the
side effects of anticancer agents [8].
Apoptosis can be initiated by a variety of intrinsic
signals, such as hormones, reactive oxygen species (ROS),
hypoxia, toxins and radiations, or extrinsic signals during
normal development [9]. Extensive production of ROS by
natural products is an important stimulus, which causes
perturbation in the inner mitochondrial membrane leading
to an opening of the mitochondrial permeability transition
pores (MPTP) [10], collapse in mitochondrial membrane
potential (MMP) [11] and leakage of several apoptogenic
factors [12]. Cytochrome c release from mitochondria to
cytosol is associated with the critical actions of Bcl-2 fam-
ily of proteins in activating the caspase cascade through
apoptosome formation [13]. The activation of executioner
caspases induces the irreversible programmed cell death of
apoptosis, which provides an effective approach to cancer
therapy [5,13].
The majority of pharmaceutical progresses rely upon
nutraceuticals for development of new phytochemical
agents with therapeutic values [14]. Curcuma purpurascens
BI. commonly known as ‘Koneng Tinggang’ and ‘Temu Tis’
is a member of the Zingiberaceae family comprising 50 gen-
era and over 1000 species, which generally consists of herb-
aceous plants from tropical forests [15-17]. C. purpurascens
is an herb (55–70 cm× 19–23 cm) with branched rhizome,
which grows spontaneously in teak forest. Same as other
curcuma species, its rhizome is extensively used as a spice
and as folk medicine [18]. Rural communities in Indonesia
use this plant for treatment of wounds, boils, cough, itch,
scabies and fever [16,19]. In this study, we investigated the
cytotoxic effect of dichloromethane extract of C. purpuras-
cens rhizome (DECPR) on human colon cancer HT-29
cells. Additionally, we also evaluated the apoptotic-inducing
effect of DECPR and suggested a possible molecular
mechanism underlying the observed activity.
Methods
Sample collection and preparation of extracts
The C. purpurascens rhizome studied in this work was
collected from Yogyakarta, Indonesia. The botanicalidentification was made by Mr. Teo Leong Eng., Faculty of
Science, University of Malaya. A voucher specimen (KL
5793) was deposited in the herbarium of the Chemistry de-
partment, Faculty of Science, University of Malaya, Kuala
Lumpur, Malaysia. The air-dried and powdered rhizomes
(1.0 kg) were subjected to extraction using n-hexane
followed by dichloromethane. The resulting filtrate of the
rhizome was concentrated by a rotary evaporator at 40°C.
The extracts were stored at −20°C and dissolved in di-
methyl sulfoxide (DMSO) for further in vitro experiments.
Samples of DECPR administered to animals were dissolved
in the vehicle 10% Tween 20.Cell lines and culture conditions
CCD841 (normal human colon epithelial cell line), HepG2
(human hepatoma cell line), HT-29 (human colon cancer
cell line), MDA-MB-231 (human breast cancer cell line),
PC-3 (human prostate cancer cell line) and WRL-68 (hu-
man hepatic cell line) were purchased from the American
Type Culture Collection (ATCC, Manassas, VA, USA) and
maintained in RPMI-1640 (Sigma, St. Louis, Mo, USA)
supplemented with 10% fetal bovine serum (PAA Lab,
Pashing, Austria), 100 U/mL penicillin and 100 mg/mL
streptomycin (PAA Lab) in a humidified atmosphere with
5% CO2 at 37°C. Untreated medium containing vehicle
DMSO (0.1%) was used as a negative control in this study.Cell proliferation assay
In vitro cytotoxic effect of DECPR was determined using
MTT assay as previously described [20]. In brief, cells (5 ×
104 cells/mL) were treated with various concentrations of
DECPR in a 96-well plate and incubated for 24 h. After
incubation time, the MTT solution (5 mg/mL, 20 μL) was
added and the plate was incubated for 2 h. DMSO
(100 μL) was then used to dissolve the formazan crystals.
The absorbance was measured at 570 nm with a micro-
plate reader (Asys UVM340, Eugendorf, Austria). The sup-
pressive effect of DECPR was expressed as IC50 value. The
anticancer drug, 5-Fluorouracil (5-FU, Sigma, St. Louis,
MO, USA) was used as a positive control towards HT-29
cells.GC-MS-TOF analysis of DECPR
The gas chromatography analysis of DECPR was per-
formed using an Agilent and LECO. RESTEK, Rxi-5MS ca-
pillary column (30 m, 0.25 mm i.d., 0.25 μm film thickness)
and a mass spectrometer Pegasus HT High Throughput
TOFMS, as previously described in detail [21]. Compounds
were identified from their mass spectra, by comparison of
the retention times of peaks with interpretation of MS
fragmentation patterns from the National Institute of Stan-
dards and Technology (NIST147) Mass Spectral Database.
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Adult female Sprague–Dawley rats weighing 180–200 g
and aged 6–8 weeks were purchased from the Animal
Experimental Unit, University of Malaya, Kuala Lumpur,
Malaysia. The rats were kept in cages of six animals each,
with food and water ad libitum at 27 ± 2°C temperature
with a 12 h light/dark cycle and with lights on at 07.00 h.
The animals were maintained and used after approval by
the Animal Ethics Committee, Faculty of Medicine, Uni-
versity of Malaya (Ethics No. 2014-03-05/PHAR/R/ER),
which is based on the guide for the Care and Use of
Laboratory Animals prepared by the National Academy
of Sciences and published by the National Institute of
Health.
Acute toxicity (if any) of DECPR was carried out as
previously described in detail [22]. In brief, a total of 18
female rats were divided into 3 groups (n = 6) and admin-
istered orally with vehicle (10% Tween 20, 5 mL/kg),
DECPR (low dose, 2 g/kg) and DECPR (high dose, 5 g/kg).
Animals were monitored for any sign of toxicity, including
clinical, toxicological symptoms and mortality over a
period of 2 weeks. On day 15th, rats were sacrificed for
further histological, hematological and serum biochemical
evaluations.Lactate dehydrogenase (LDH) release assay
Release of LDH from treated colon cancer cells was mea-
sured using Pierce LDH Cytotoxicity Assay Kit (Thermo
Scientific, Pittsburgh, PA, USA), as previously described
[23]. Briefly, HT-29 cells were treated with different con-
centrations of DECPR for 24 h. To determine the LDH
leakage, the supernatant of treated cells was transferred in
96-well plate. Triton X-100 (2%) as positive control was
used to completely lyse the cells and release the maximum
LDH. Then, the LDH reaction solution (100 μl) was added
to the cells for 30 min. The red color intensity represent-
ing the LDH activity was measured at the absorbance of
490 using a Tecan Infinite 200 Pro (Tecan, Männedorf,
Switzerland) microplate reader. The level of released LDH
from treated colon cancer cells was expressed as a per-
centage of positive control.Cytoskeletal arrangement assay
To determine the effect of DECPR on the cytoskeletal re-
arrangement, we used Cellomics Cytoskeletal Rearrange-
ment Kit (Thermo Scientific, Pittsburgh, PA, USA) as
previously described in detail [24]. In brief, HT-29 cells at
the exponential phase of growth were treated with differ-
ent concentrations of DECPR for 24 h. Then, treated cells
were fixed and stained with Hoechst and phalloidin dyes
according to the vendor’s instructions. At the end, the
stained cells were examined for changes in cytoskeletalrearrangement using ArrayScan HCS system (Cellomics
Inc, Pittsburgh, PA, USA).
Reactive oxygen species (ROS) generation assay
To determine the effect of DECPR on ROS generation in
colon cancer cells, we carried out ROS assay [25]. Briefly,
HT-29 cells (1 × 104 cells/well) were seeded in a 96-well
plate for 24 h. Then, colon cancer cells were treated with
different concentrations of DECPR and incubated over-
night. After the incubation time, treated cells were stained
with dihydroethidium (2.5 μg/mL, 50 μL) and Hoechst
33342 (500 nM) for 30 min. Next, cells were fixed with
paraformaldehyde (3.5%) for 15 min and washed with PBS
twice. Formation of ROS in treated cells was measured
using a Cellomics ArrayScan HCS reader (Cellomics Inc,
Pittsburgh, PA, USA).
Multiple cytotoxicity assay
The important characterizations of mitochondrial depen-
dent apoptosis, including changes in cytochrome c release
and mitochondrial membrane potential (MMP) in addi-
tion to cell membrane permeability were measured using
a Cellomics Multiparameter Cytotoxicity 3 Kit as previ-
ously described in details by Lövborg and colleagues [26].
The fixed and stained HT-29 cells were exhaustively ana-
lyzed using the ArrayScan HCS system (Cellomics Inc,
Pittsburgh, PA, USA).
DNA fragmentation assay
A suicide- Track DNA Ladder isolation kit (Calbiochem,
San Diego, CA, USA) was used to observe DNA frag-
ments (mononucleosome and oligonucleosomes) formed
during apoptosis. In brief, HT-29 cells were seeded at the
density of 5 × 104 cells/mL in a culture flask, and incu-
bated for 24 h. They were then treated with DECPR at
12.5 and 25 μg/mL concentrations for 24 h. The treated
cells were trypsinized and centrifuged at 1,000 rpm for
10 min. The pellet was gently re-suspended in 55 μl of
solution #1 (kit component). It was then mixed with 20 μl
of re-suspension buffer. To detect the DNA ladder, the ex-
tracted DNA samples were run on the 1.5% agarose gel in
a Tris-acetic- EDTA buffer. After electrophoresis, the gel
was stained with Novel Juice Cat No. LD001-1000, visual-
ized with a UV light transilluminator, and photographed.
Caspase-3, −8 and −9 activities assay
Activation of caspases was measured using the fluoromet-
ric assay kit (Calbiochem), according to the manufac-
turer’s protocol. In brief, HT-29 cells at the exponential
phase of growth were supplemented with DECPR at dif-
ferent concentrations for 24 h. The treated cells were har-
vested prior to the preparation of cell lysates as described
previously [27]. After the incubation, the cell lysates were
Table 1 IC50 values of C. purpurascens rhizome extracts on six different cell lines after 24 h treatment
Extract Cell lines, IC50 (μg/mL)
HT-29 HepG2 PC-3 MDA-MB-231 CCD841 WRL-68
Hexane 14.16 ± 1.04 16.78 ± 1.45 18.21 ± 0.91 31.10 ± 1.45 61.28 ± 2.41 73.27 ± 3.41
Dichloromethane 7.79 ± 0.54 10.26 ± 0.78 12.41 ± 1.01 18.48 ± 1.65 57.46 ± 2.34 69.74 ± 3.85
The data represent the means ± SEM of three independent experiments.
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caspase-8: z-IETD-FMK; caspase-9: z-LEHD-FMK). After
30 min, reaction buffer and fluorogenic peptide substrate
(10 μL): Ac-DEVD-AMC (caspase-3), Ac-IETD-AMC
(caspase-8) and Ac-LEHD-AMC (caspase-9) were added
to the cell lysates, and incubated at 37°C in the dark for
2 h. The activation of caspases in DECPR-treated HT-29
cells was measured using the Tecan Infinite 200 Pro
(Tecan, Mannedorf, Switzerland) microplate reader at
excitation of 390 nm and emission of 500 nm [24].
Quantitative PCR analysis for Bax, Bcl-2 and Bcl-xl
The gene expression of Bax, Bcl-xl and Bcl-2 proteins
in treated HT-29 cells was measured by quantitative
PCR analysis [24]. Briefly, Zymo Research Quick-RNA
MiniPrep kit (Zymo Research, Freiburg, Germany) was
used to isolate total RNAs of HT-29 cells after 24 h
treatment with DECPR at IC50 concentration. Next,
complementary DNAs was synthesized using High Cap-
acity RNA-to-cDNA kit (Applied Biosystems, Foster
City, CA, USA), according to the vendor’s protocol.
Quantitative PCR was performed with TaqMan Fast
Advanced Master Mix and TaqMan Gene Expression
Assays using the Applied Biosystems StepOnePlus
Real-Time PCR (Applied Biosystems, Foster City, CA,
USA). The IDs for TaqMan Gene Expression Assays
used in this study are Bax: Hs00180269_m1, Bcl-xl:
Hs00236329_m1, Bcl-2: Hs00608023_m1 and GAPDH:
Hs02758991_g1.Figure 1 A GC-MS-TOF chromatogram of the chemical constituents oWestern blotting
To confirm the changes of mRNA expression detected
from quantitative PCR analysis, western blot assay was
performed as previously described [24]. In brief, after
treatment of HT-29 cells (1 × 106 cells/mL) with DECPR
at different concentrations for 24 h, cells were washed
with PBS and lysed in ice-cold Radio Immuno Precipita-
tion Assay buffer (RIPA, Thermo Scientific (Rockford,
IL, USA). Protein separation was carried out on 10% re-
solving polyacrylamide gels (i.e., SDS-PAGE) followed by
electroblotting at 25 mA for 2 h. After transforming the
proteins to polyvinylidene fluoride membrane (Pierce,
Rockford, IL, USA), the membrane was blocked using a
Blocker Casein (Pierce). The blots were incubated over-
night with specific primary antibodies; β-actin 1:10000
(Cat: ab6276, Abcam), Bax 1:1000 (Cat: ab7977, Abcam),
Bcl-2 (1:1000 Cat: ab18210, Abcam), Bcl-xl (1:1000 Cat:
ab32310, Abcam), and then exposed to peroxidase-
coupled secondary antibodies for 2 h. Subsequent
detection of protein expression was carried out using
the Fusion FX7 system (Vilber Lourmat, Eberhardzell,
Germany).
Statistical analysis
The results were presented as the mean ± SEM of the
three independent experiments. A one-way analysis of
variance (ANOVA) was performed using the prism stat-
istical package (GraphPad Software, USA). P< 0.05 was
considered statistically significant.f DECPR.
Table 2 The possible compounds in DECPR were
characterized using a GC-MS-TOF analysis
Peak no. Name of compounds Retention time (s) Mass
1 c-Elemene 1810.45 189
2 a-Elemenone 2119 218
3 ar-Turmerone 2235.55 216
4 Turmerone 2245.75 218
5 Curlone 2319.85 218
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DECPR showed the strongest cytotoxic effect on HT-29 cells
To determine the effects of hexane and dichloromethane
extracts of C. purpurascens rhizome on human cancer
cells, the viability of four different cancer cell lines after
24 h treatment with the extract was examined using MTT
assay. As shown in Table 1, hexane and dichloromethane
extracts showed the extensive range of cytotoxic effects
towards cancer cells (IC50 ranged from 7.79 ± 0.54 to
31.10 ± 1.45 μg/mL). The results showed that DECPR
induced the higher cytotoxic effects on cancer cells when
compared with the hexane extract. Furthermore, DECPR
elicited the strongest anti-proliferative effect on HT-29
colon cancer cells with the IC50 value of 7.79 ± 0.54 μg/
mL. 5-FU, the standard anticancer drug, exhibited the
IC50 value of 4.56 ± 0.67 μg/mL against HT-29 cells after
24 h treatment. The relatively higher IC50 value of DECPR
on WRL-68 and CCD841 compared to the cancer cells
suggested the safety of this plant on normal human cells
and its selective cytotoxic effects. Since DECPR showed
the strongest suppressive effect towards HT-29 cells, we
carried out the further experiments only on the respective
colon cancer cell.
GC-MS-TOF profile of DECPR
As shown in Figure 1, the dichloromethane extract of C.
purpurascens was characterized with a GC-MS-TOF ana-
lysis. The gas chromatography profile of DECPR showedFigure 2 Histological analysis. Histological sections of kidney and liver in ra
and DECPR (5 g/kg) showed no sign toxicity in these organs.that the detected compounds in DECPR are c-Elemene
(1), a-elemenone (2), ar-turmerone (3), turmerone (4) and
curlone (5), with turmerone (4) as the major compound
(Table 2).
Safety of DECPR
In the acute toxicity analysis, the rats were orally adminis-
tered with DECPR at dosages of 2 g/kg and 5 g/kg and
were monitored for 2 weeks. The result of study did not
reveal any report for mortality or any sign of toxicity in
rats. There was no detectable sign of toxicity in serum bio-
chemical and hematological parameters of the treated
groups compared with the vehicle group (Additional file 1:
Table S1). The histological analysis showed the structures
of the kidney and liver remain normal confirming the
safety of DECPR at the doses tested (Figure 2).
Induction of LDH leakage by DECPR
Any kind of cell’s demise, including apoptosis and necrosis
is associated with LDH release caused by irreversible cell
membrane damage. Hence, measurement of the LDH
leakage from cells into the medium is an easy marker to
determine the cytotoxic activity [28]. In order to confirm
the anti-proliferative effect of DECPR observed in MTT
assay, we measured the level of released LDH from HT-29
cells after 24 h of treatment. As depicted in Figure 3,
DECPR caused a significant and dose-dependent elevation
in LDH release at 12.5 to 50 μg/mL concentrations, com-
pared to the control. The results of MTT and LDH assays
together confirmed the noticeable antiproliferative effect
of DECPR towards HT-29 cells.
Induction of cytoskeletal rearrangement and nuclear
fragmentation by DECPR
Since DECPR showed a significant cytotoxic potential
towards HT-29 cells, further mechanistic studies were
carried out with this extract. To investigate the cytoskel-
etal and nuclear changes in HT-29 cells after DECPRts after treatment with 5 mL/kg vehicle (10% Tween 20), DECPR (2 g/kg)
Figure 4 Effect of DECPR on cell membrane permeability, MMP
and cytochrome c release. (A) HT-29 cells were treated with different
concentrations of DECPR for 24 h and stained with Hoechst 33342 (blue)
for nucleus and phalloidin (red) for polymerized actin (F-actin). White
arrows depict DNA fragmentation and shrinkage. (B) Representative bar
chart showed the significant reduction in fluorescent intensity of
phalloidin at 12.5 to 50 μg/mL concentrations showing the cytoskeletal
rearrangement induced by DECPR. The data represent the means ± SEM
of three independent experiments. *P < 0.05 compared with the
untreated group.
Figure 3 LDH assay elicited the cytotoxicity of DECPR towards
HT-29 cells. The result showed significant LDH release at concentrations
of 12.5 to 50 μg/mL, in a dose-dependent manner. The data represent
the means ± SEM of three independent experiments. *P< 0.05 compared
with the untreated group.
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to detect perturbation in nucleus and F-actin, respect-
ively. As illustrated in Figure 4A, HT-29 treated cells
elicited the clear sign of DNA shrinkage and fragmenta-
tion after 24 h of treatment. In addition, F-actin pertur-
bations at the peripheral membrane of HT-29 cells
revealed the cytoskeletal rearrangements induced by
DECPR, which showed to be significant at 12.5 to 50 μg/
mL concentrations (Figure 4B). These morphological
changes suggest the induction of apoptosis by DECPR.
Induction of ROS generation by DECPR
The level of ROS in HT-29 cells after DECPR treatment
was examined using the oxidative-sensitive dihydroethi-
dium probe which converts to fluorescent ethidium and
intercalates into DNA as a result of ROS generation.
When HT-29 cells were treated with DECPR for 24 h,
ethidium derived fluorescence dose-dependently increased
showing the capacity of DECPR to cause intracellularFigure 5 Effect of DECPR on ROS generation in HT-29 cells. (A)
HT-29 cells were treated with vehicle DMSO or DECPR at 12.5 μg/mL
concentration, stained with Hoechst 33342 dye (blue) for nucleus and
dihydroethidium for ROS detection. (B) Representative bar chart
showed significant ROS generation at 6.25 to 50 μg/mL concentrations
after 24 h treatment with DECPR. The data represent the means ± SEM
of three independent experiments. *P < 0.05 compared with the
untreated group.
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fluorescent intensity with HSC system demonstrated
significant ROS production at 6.25 to 50 μg/mL con-
centrations (Figure 5B). The level of ROS was elevated
to more than 2-fold at 12.5 μg/mL concentration com-
pared to the control. This result showed that DECPR
can promote oxidative stress in HT-29 cells upon
treatment.
Induction of mitochondrial-initiated events by DECPR
To determine the possible mechanism of action in which
DECPR suppressed the proliferation of HT-29 cells, we
investigated the changes in the three critical apoptosis-
related factors, namely cell membrane permeability,
MMP and cytochrome c. As depicted in Figure 6A, cell
membrane permeability in control cells was marked with
green fluorescent dye, which was conspicuously elevated
in DECPR-treated cells. Meanwhile, the red fluorescent
intensity of control cells was noticeably attenuated
after DECPR treatment showing the collapse in MMP
(Figure 6A). In addition, the cyan fluorescent intensity
in control cells presenting the cytochrome c leakageFigure 6 Simultaneous analysis of DECPR effect on three different ap
concentrations for 24 h. After fixing the cells, they were stained with Hoechst
with HCS analysis of the stained cells. (B) Representative analysis of the figure
elevated the cell membrane permeability and cytochrome c release. Meanwh
MMP. The data represent the means ± SEM of three independent experimentfrom mitochondria to cytosol was markedly lightened
upon treatment with DECPR (Figure 6B). The quantitative
analysis of the fluorescent intensity of three markers
showed a dose-dependent and significant increase in cell
membrane permeability and cytochrome c leakage at
6.25 to 50 μg/mL concentrations. The MMP of treated
HT-29 cells was also significantly reduced at these
concentrations.
Induction of DNA fragmentation by DECPR
To elucidate late stage of apoptosis, DNA laddering
assay was performed. The exposure of HT-29 cells to
DECPR at 12.5 and 25 μg/mL concentrations for 24 h
led to apparent DNA fragmentation, as shown by the
formation of DNA ladders in the agarose gel (Figure 7),
whereas the control did not reveal any DNA fragmenta-
tion. The ability to cause DNA fragmentation is one of
the hallmarks of late apoptotic cell death.
Induction of caspases activation by DECPR
Since morphological and biochemical characterizations
of apoptosis were observed in DECPR-treated HT-29optotic markers. (A) HT-29 cells were treated with DECPR at different
33342, membrane permeability, MMP and cytochrome c dyes following
s showed that DECPR at 6.25 to 50 μg/mL concentrations significantly
ile, at 12.5 to 50 μg/mL concentrations, there was a significant collapse in
s. *P < 0.05 compared with the untreated group.
Figure 7 DECPR induced DNA fragmentation in HT-29 cells.
Cells were exposed to DECPR at 12.5 and 25 μg/mL concentrations for
24 h. Doxorubicin (Dox, 10 μg/mL) was used as a positive control. After
incubation, the extracted DNA samples were run on the 1.5% agarose
gel in a Tris-acetic- EDTA buffer, stained and visualized with a UV
light transilluminator.
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key mediators of apoptosis using a fluorometric analysis.
Between initiator caspase-8 and −9, DECPR only in-
duced the activity of caspase-9 with dose-dependent and
significant elevation at 6.25 to 50 μg/mL concentrations.
Meanwhile, the activity of initiator caspase-8 elicited no
significant perturbation. In addition, the activation of
executioner caspase-3 was significantly increased at the
same concentrations (Figure 8). To prove the role of
caspases in DECPR-induced apoptosis, specific inhibitors
of caspases were supplemented in HT-29 treated cells.
In the presence of inhibitors, fold elevation of caspase-3
and caspase-9 significantly decreased (Figure 8). The re-
sults of caspases activity associated with MMP changes
and cytochrome c release strongly suggest the induction
of mitochondrial-mediated apoptosis by DECPR.
Changes in expression of apoptosis-associated molecules
by DECPR
Bcl-2 family of proteins has critical role in the regulation
of mitochondrial-mediated apoptosis, and perturbation
in the expression of these genes trigger a variety of
biochemical changes. Hence, we examined the mRNA
expression of the pro-apoptotic and anti-apoptoticmolecules upon treatment with DECPR. Pro-apoptotic
gene, Bax showed dose-dependent and significant
mRNA up-regulation after 24 h treatment with DECPR
at 12.5 to 50 μg/mL concentrations. Meanwhile, at the
same concentrations, there was a significant down-
regulation in the mRNA expression of Bcl-2 and Bcl-xl
(Figure 9A). These changes were also confirmed at the
protein level using a western blot analysis (Figure 9B).
Discussion
Plants from Curcuma genus represented by the turmeric
spice, such as C. longa, C. phaeocaulis, C. wenyujin and C.
kwangsiensis are well known to be valuable herbal medi-
cines [29]. Due to the extensive biological activity reported
for the chemical constituents of these plants, including
anti-Alzheimer’s disease [30], anti-inflammatory [31], anti-
angiogenesis [32] and anti-microbial [33], a number of sci-
entific works have been carried out on Curcuma species.
The safety of these plants and their active compounds in
animal studies in a number of species have been con-
firmed. However, some species were found to be suscep-
tible to hepatotoxicity at high doses of turmeric [34,35].
The present study demonstrated the safety of DECPR in
rats even at high dose of 5 g/kg without any sign of renal
or hepatic dysfunction. In spite of numerous studies on
Curcuma species, there is no report on biological activity
of C. purpurascens, in special anti-cancer potential.
Hence, in the current experiment, cytotoxic effect of C.
purpurascens on different cancer cells was examined.
Our result showed a promising suppressive effect of
DECPR against HT-29 cells observed by MTT and LDH
assays.
The growing body of experimental evidences supports
the extensive anticancer effect of Curcuma species and
their chemical constituents, known as curcuminoids, to-
wards different cancer cells [36-40]. In vivo studies and
clinical trials for the treatment of various tumors have
highlighted the role of curcuminoids and their analogues
as promising therapeutic agents. Turmerone and its de-
rivatives as major compounds detected in DECPR were
previously reported to have apoptotic effect towards dif-
ferent cancer cells, such as HL-60, MCF-7, MDA-MB-231
and HepG2 cancer cells [41,42]. However, the apoptotic
effect of turmerone and its mechanism of action on HT-
29 cells have been not fully illustrated yet.
Apoptosis generally defines with specific morphological
characterizations, including cell shrinkage, nuclear or
cytoplasmic fragmentations, chromatin condensation and
formation of dense bodies that are phagocyted by
neighboring cells [43]. It is well established that re-
structuring of actin cytoskeleton has a critical role in
the formation of morphological changes in apoptotic cells
[44]. Our study indicated that DECPR treatment induced
nuclear shrinkage and fragmentation after 24 h. This
Figure 8 DECPR induced caspase-3 and −9 activation in HT-29 cells. Cells were treated with different concentrations of DECPR for 24 h, in
the presence or absence of specific inhibitors, following with a fluorometric analysis of caspases activities. Treated cells without inhibitors showed
the significant activation for caspase-3 and −9 at 6.25 to 50 μg/mL concentrations, while there was no significant fold-change in caspase-8 activity. The
data represent the means ± SEM of three independent experiments. *P < 0.05 compared with the untreated group.
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Figure 9 DECPR induced changes in expression of mitochondrial-dependent proteins. (A) Quantitative PCR analysis of apoptosis-associated
genes in HT-29 cells showed significant up-regulation of Bax and down-regulation of Bcl-2 and Bcl-xl at the mRNA level. The data represent the
means ± SEM of three independent experiments. *P < 0.05 compared with the untreated group. (B) Western blot analysis confirmed up-regulation
of Bax and down-regulation of Bcl-2 and Bcl-xl at the protein level.
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lymerizations in the treated HT-29 cells. Previous studies
showed that standard anticancer drugs such as cisplatin
and tamoxifen cause F-actin damages prior to the induc-
tion of nuclear changes in cancer cells [45,46].
ROS can generate nonradical derivatives of oxygen,
such as H2O2 and free radicals, namely hydroxyl radical
(OH−) and superoxide (O2) [47]. The excessive produc-
tion of free radicals has been demonstrated to accelerate
cell death by inducing severe damages to DNA, lipid
membranes and proteins of cells [48]. In the current
study, we found that DECPR significantly induced ROS
generation in HT-29 cells. A previous study showed that
prime initiating signaling factor of ROS was markedly
involved in three different signaling pathways of apop-
tosis induced by curcumin in L929 cells showing the
critical role of ROS generation in the suppressive effect
of different anticancer agents [49]. It is well-established
that numerous apoptotic stimuli, including ROS gener-
ation, initiate apoptosis by disturbing mitochondrial func-
tion sufficiently to trigger leakage of cytochrome c from
mitochondria [50]. Production of MMP across the mito-
chondrial inner membrane is the result of utilization of
oxidizable substrates, therefore excessive generation of
ROS in cells may lead to the loss in MMP [51]. This is
showed by HSC analysis on HT-29 cells after DECPR
treatment which demonstrated significant reduction in
MMP and elevation in cell membrane permeability and
cytochrome c release.
Cytochrome c release from mitochondria to cytosol
activates the initiator and executioner caspases involved
in the intrinsic pathway of apoptosis [52,53]. The bio-
chemical changes of this apoptotic pathway are mediated
and tightly regulated by Bcl-2 family of proteins,including pro-apoptotic and anti-apoptotic proteins [54].
Cytochrome c release is mediated through dimerization of
Bax and Bak as a pro-apoptotic proteins [55]. On the
other hand, activity of pro-apoptotic proteins is facilitated
through inhibition of anti-apoptotic proteins, e.g. Bcl-2
and Bcl-xl by intracellular stress signals [56]. In the
present experiment, DECPR caused a dramatic cyto-
chrome c leakage to cytosol in HT-29 cells as a key factor
in apoptosome formation which leads to the cleavage of
procaspase-9 to caspase-9 [57]. The investigation on the
activation of caspases upon treatment with DECPR
demonstrated the elevation in the activity of caspase-3
and −9. According to these data, it is strongly conceiv-
able that ROS production in HT-29 cells triggered the
mitochondrial-initiated events leading to the cytochrome
c release and activation of caspase cascade. Our investiga-
tions on the mRNA expression of apoptosis-associated
proteins also supported the induction of apoptosis
through mitochondrial-mediated pathway.Conclusions
This is the first report on the noteworthy suppressive ef-
fect of Curcuma purpurascens BI. rhizome against cancer
cells. Our results strongly suggest that DECPR induced
apoptosis in HT-29 cells by activating the mitochondrial
death pathway via the involvement of Bcl-2/Bax/Bcl-xl
and ROS production. However, we do not know whether
apoptosis induced by DECPR relies on a single or com-
bined effects of different compounds detected in this
extract. Therefore, further study with bioassay guided ap-
proach is still required to fully explain the apoptosis-
inducing effect of DECPR and the chemical constituents
involved in this activity.
Rouhollahi et al. BMC Complementary and Alternative Medicine  (2015) 15:15 Page 11 of 12Additional file
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